carteolol has been researched along with Experimental Neoplasms in 1 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurosumi, M | 1 |
| Hatori, M | 1 |
| Nishino, H | 1 |
1 other study available for carteolol and Experimental Neoplasms
| Article | Year |
|---|---|
Carcinogenicity of carteolol hydrochloride in Balb/c mice.
Topics: Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Carcinogens; Carteolol; Female; Male; Mice | 1979 |